oral retatrutide drops Retatrutide, a new weight loss drug not available on the market yet, is showing promising results in trials. @DrLaPook explains it's doing much more than what current medications can Retatrutide—A Game Changer in Obesity

The compound received marketing approval in China in June 2025 under the brand name Xinermei, making it the first domestically approved dual GLP-1/glucagon agonist anywhere in the world

Premium API Retatrutide Peptide Name: Retatrutide CAS Number: 2381089-83-2 Formula: C 221 H 342 N 46 O 68 Molecular Weight: 4731g/mol Sequence: YAQGT FTSDY SILLD KKAQA AFIEY LLEGG PSSGA PPPS Purity: 98% Type: Drug Peptides, Synthetic peptide Premium API Retatrutide Description Retatrutide is a triple agonist, it targets the glucagon receptor, gastric inhibitory polypeptides, glucagon-like peptide-1

These findings indicate that fat-rich obesogenic diets alter intestinal homeostasis, which decreases GLP-1 production

Reconstituted retatrutide should be stored in the refrigerator at 2 to 8 degrees Celsius and used within 28 to 30 days

Label: RETATRUTIDE PEN injection, solution

A 2022 study published in the New England Journal of Medicine (Wilding et al.) found that participants who stopped semaglutide regained approximately two-thirds of their prior weight loss within 12 months